Itay&Beyond Develops a Drug Discovery Platform to Establish the Next Generation of Treatments for Psychiatric and Neurological Disorders.
These Compounds Will Be Going Through a Unique and Patented Estimation of Their Clinical Efficacy Using the Novel Technology that Underlies Our Drug Discovery Platform. The Most Promising Compounds Will Go On for Pre-Clinical Studies.
Our Business Opportunities include Licensing, Co-Development, and Sells of Drugs Developed Up to pre-IND.
Established in 2021, Itay&Beyond is an Innovative Company that Develops a Drug Discovery Platform for the Treatment Neuropsychiatric Disorders.
Itay&Beyond is Led by a Strong and Experienced Team of Professionals and Scientists with Expert Know-How and Experience in the BioTech Pharma Industries.
Itay&Beyond Delivers an Innovative, Salable and Cost-Effective Biologics Model Based on AI-Driven Predictive Analytics and Advanced Biotechnology Methods.
Together with Hadassah Hospital in Jerusalem, We are Currently Validating Our Drug Discovery Platform Using Samples from 200 Patients.
Itay&Beyond Holds Four Issued US patents with PCT Extensions.
Our Drug Discovery Platform Has the Potential to Develop Treatments to a Wide Range of Previously Untreatable Neuropsychiatric Disorders.
English 
Arabic